Human cells typically oxidize glucose using oxygen to produce ATP (adenosine triphosphate), the energy currency essential for cellular functions. However, cancer cells deviate from this pathway. Instead, they rely on glycolysis to generate ATP, even when oxygen is abundant. This process converts glucose into pyruvic acid and lactic acid, a phenomenon known as the Warburg effect. Although this method is inefficient, it remains the preferred energy strategy for cancer cells, raising questions about its role in tumor survival and proliferation.
Exploring Alternative Energy Pathways in Cancer
To uncover why cancer cells favor this inefficient energy process, Associate Professor Akiko Kojima-Yuasa and her team from Osaka Metropolitan University’s Graduate School of Human Life and Ecology investigated ethyl p-methoxycinnamate, a cinnamic acid ester found in kencur ginger. Their earlier studies revealed the compound’s inhibitory effects on cancer cells. In this extended research, the team administered the compound to Ehrlich ascites tumor cells to determine which part of the cancer cells’ energy metabolism it influenced.
Disrupting Lipid Metabolism, Not Glycolysis
As reported by sciencedaily, the study found that ethyl p-methoxycinnamate inhibited ATP production by interfering with de novo fatty acid synthesis and lipid metabolism, rather than directly targeting glycolysis. Interestingly, the disruption in lipid metabolism caused the cancer cells to increase glycolysis—possibly as a compensatory survival mechanism. However, despite this shift, the compound did not induce cell death, suggesting the cells adapted to maintain their energy supply.
New Insights into Cancer Metabolism
These findings provide a fresh perspective on cancer metabolism. While they support and expand on the foundational Warburg effect, they also highlight an underexplored aspect—cancer cells’ reliance on fatty acid synthesis for ATP production. According to Professor Kojima-Yuasa, these insights could pave the way for new therapeutic targets and novel treatment approaches in cancer care.